Advanced glycation end products activate Smad signaling via TGF‐β‐dependent and ‐independent mechanisms: implications for diabetic renal and vascular disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
While it is thought that advanced glycation end products (AGEs) act by stimulating transforming growth factor (TGF)‐β to mediate diabetic injury, we report that AGEs can activate TGF‐β signaling, Smads, and mediate diabetic scarring directly and independently of TGF‐β. AGEs activate Smad2/3 in renal and vascular cells at 5 min, peaking over 15–30 min before TGF‐β synthesis at 24 h and occurs in TGF‐β receptor I and II mutant cells. This is mediated by RAGE and ERK/p38 mitogen‐activated protein kinases (MAPKs). In addition, AGEs also activate Smads at 24 h via the classic TGF‐β‐dependent pathway. A substantial inhibition of AGE‐ induced Smad activation and collagen synthesis by ERK/p38 MAPK inhibitors, but not by TGF‐β blockade, suggests that the MAPK‐Smad signaling crosstalk pathway is a key mechanism in diabetic scarring. Prevention of AGE‐induced Smad activation and collagen synthesis by overexpression of Smad7 indicates that Smad signaling may play a critical role in diabetic complications. This is further supported by the findings that activation of Smad2/3 in human diabetic nephropathy and vasculopathy is associated with local deposition of AGEs and up‐ regulation of RAGE. Thus, AGEs act by activating Smad signaling to mediate diabetic complications via both TGF‐β‐dependent and ‐independent pathways, shedding new light on the pathogenesis of diabetic organ injury.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling TGF-beta signaling.
Massagué, J., & Chen, Y. (2000) · PubMed · Cited by 1,976
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Massagué, J., & Chen, Y.-G. (2000) · Genes & Development · doi:10.1101/gad.14.6.627 · Cited by 1,575
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
TGFβ signals through a heteromeric protein kinase receptor complex
Wrana, J. L., Attisano, L., Cárcamo, J., Zentella, A., Doody, J., Laiho, M., Wang, X.-F., & Massague, J. (1992) · Cell · doi:10.1016/0092-8674(92)90395-s · Cited by 1,526
The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses
Schmidt, A. M., Yan, S. D., Yan, S. F., & Stern, D. M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci14002 · Cited by 1,253
Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205
Self-citationPark, L., Raman, K. G., Lee, K. J., Lu, Y., Ferran, L. J., Chow, W. S., Stern, D., & Schmidt, A. M. (1998) · Nature Medicine · doi:10.1038/2012 · Cited by 1,104
Ziyadeh, F. N., Hoffman, B. B., Han, D. C., Iglesias-de la Cruz, M. C., Hong, S. W., Isono, M., Chen, S., McGowan, T. A., & Sharma, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120055097 · Cited by 907
Lander, H. M., Tauras, J. M., Ogiste, J. S., Hori, O., Moss, R. A., & Schmidt, A. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17810 · Cited by 813
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Self-citationMechanisms, Pathophysiology, and Therapy of Arterial Stiffness
Zieman, S. J., Melenovsky, V., & Kass, D. A. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160548.78317.29 · Cited by 1,854
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
TGF-β/Smad signaling in renal fibrosis
Meng, X.-M., Tang, P. M.-K., Li, J., & Lan, H. Y. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00082 · Cited by 666
Self-citationDiverse Roles of TGF-β/Smads in Renal Fibrosis and Inflammation
Lan, H. Y. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.1056 · Cited by 652
Self-citationTGF-β signaling in vascular fibrosis
RUIZORTEGA, M., RODRIGUEZVITA, J., SANCHEZLOPEZ, E., CARVAJAL, G., & EGIDO, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.008 · Cited by 492
Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
Zhong, X., Chung, A. C. K., Chen, H.-Y., Meng, X.-M., & Lan, H. Y. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111168 · Cited by 409
Self-citationVascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical Implications
Harvey, A., Montezano, A. C., Lopes, R. A., Rios, F., & Touyz, R. M. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.070 · Cited by 383
Falcone, C., Emanuele, E., D’Angelo, A., Buzzi, M. P., Belvito, C., Cuccia, M., & Geroldi, D. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160342.20342.00 · Cited by 377
Role of the TGF-β/BMP-7/Smad pathways in renal diseases
Meng, X.-M., Chung, A. C. K., & Lan, H. Y. (2013) · Clinical Science · doi:10.1042/cs20120252 · Cited by 354
Self-citationmiR-192 Mediates TGF-β/Smad3-Driven Renal Fibrosis
Chung, A. C. K., Huang, X. R., Meng, X., & Lan, H. Y. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020134 · Cited by 354
Self-citationRole of Advanced Glycation End Products in Diabetic Nephropathy
Forbes, J. M., Cooper, M. E., Oldfield, M. D., & Thomas, M. C. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077413.41276.17 · Cited by 351
Self-citationTransforming growth factor‐β and Smad signalling in kidney diseases: Review Article
WANG, W., KOKA, V., & LAN, H. Y. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00334.x · Cited by 347
Self-citationThe Role of AGE/RAGE Signaling in Diabetes-Mediated Vascular Calcification
Kay, A. M., Simpson, C. L., & Stewart, J. A. (2016) · Journal of Diabetes Research · doi:10.1155/2016/6809703 · Cited by 346
The origin of renal fibroblasts/myofibroblasts and the signals that trigger fibrosis
Sun, Y. B. Y., Qu, X., Caruana, G., & Li, J. (2016) · Differentiation · doi:10.1016/j.diff.2016.05.008 · Cited by 341
Self-citationRodríguez-Vita, J., Sánchez-López, E., Esteban, V., Rupérez, M., Egido, J., & Ruiz-Ortega, M. (2005) · Circulation · doi:10.1161/01.cir.0000165133.84978.e2 · Cited by 327
Li, J., Qu, X., & Bertram, J. F. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090096 · Cited by 316
Self-citationPathophysiology of the Diabetic Kidney
Vallon, V., & Komers, R. (2011) · Comprehensive Physiology · doi:10.1002/cphy.c100049 · Cited by 259
Vincent, A. M., Perrone, L., Sullivan, K. A., Backus, C., Sastry, A. M., Lastoskie, C., & Feldman, E. L. (2007) · Endocrinology · doi:10.1210/en.2006-0073 · Cited by 258
Essential Role of Smad3 in Angiotensin II–Induced Vascular Fibrosis
Wang, W., Huang, X. R., Canlas, E., Oka, K., Truong, L. D., Deng, C., Bhowmick, N. A., Ju, W., Bottinger, E. P., & Lan, H. Y. (2006) · Circulation Research · doi:10.1161/01.res.0000218782.52610.dc · Cited by 234
Self-citationOxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease
Wang, N., & Zhang, C. (2024) · Antioxidants · doi:10.3390/antiox13040455 · Cited by 218
TGF-Beta as a Master Regulator of Diabetic Nephropathy
Wang, L., Wang, H.-L., Liu, T.-T., & Lan, H.-Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157881 · Cited by 185
Self-citationBalogh, D. B., Wagner, L. J., & Fekete, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097789 · Cited by 38
Metadata
- Authors
- Li, J. H., Huang, X. R., Zhu, H., Oldfield, M., Cooper, M., Truong, L. D., Johnson, R. J., & Lan, H. Y.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2003-04-22
- Volume
- 18
- Issue
- 1
- Pages
- 176-178
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2147068335
- Cited by
- 264
- References
- 44
- FWCI
- 5.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.